58A-15440-18243 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-09
Dose 1 — Janssen/Johnson & Johnson
2021-11-02
Registered in v-safe
2021-11-09
Dose 2 — Moderna
2022-04-09
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in
2022-12-09
Dose 3 — Pfizer-BioNTech
2022-12-09
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-12-10
Survey response — days 1–6 daily, dose 3
MedDRA: Paraesthesia — Feeling: Good · Site: Pain, Swelling

Free text: Tingly arm (injection arm)

MedDRA releases: 2024-11 · check-in free text available
2022-12-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-12-16
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2023-01-01
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2023-01-22
Survey response — day 42, dose 3
MedDRA: Cough — Feeling: Good

MedDRA releases: 2024-11
2023-03-10
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-09	Janssen/Johnson & Johnson	No
2	2021-11-09	Moderna	No
3	2022-12-09	Pfizer-BioNTech	No

Free text

Release 12 — days 1–6 daily, dose 3

2022-12-10

Systemic reaction (other): Tingly arm (injection arm)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SRO	Paraesthesia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release